- Clinical Utility of Mac-2 Binding Protein Glycosylation Isomer in Chronic Liver Diseases
-
Tamaki N, Kurosaki M, Loomba R, Izumi N
- KMID: 2512730
- Ann Lab Med.
- 2021 Jan;41(1):16-24.
- doi: 10.3343/alm.2021.41.1.16
An accurate evaluation of liver fibrosis is clinically important in chronic liver diseases. Mac-2 binding protein glycosylation isomer (M2BPGi) is a novel serum marker for liver fibrosis. In this review,... -
- CITED
-
- Close
- SHARE
-
- Close
- Evidence-based clinical advice for nutrition and dietary weight loss strategies for the management of NAFLD and NASH
-
Hydes TJ, Ravi S, Loomba R, E. Gray M
- KMID: 2507958
- Clin Mol Hepatol.
- 2020 Oct;26(4):383-400.
- doi: 10.3350/cmh.2020.0067
Nonalcoholic fatty liver disease (NAFLD) is the most common cause of chronic liver disease worldwide and affects approximately one third of adults in the United States. The disease is becoming... -
- CITED
-
- Close
- SHARE
-
- Close
- Global prevalence of depression and anxiety in patients with hepatocellular carcinoma: Systematic review and meta-analysis
-
Tan DJH, Quek SXZ, Yong JN, Suresh A, Koh KXM, Lim WH, Quek J, Tang A, Tan C, Nah B, Tan E, Keitoku T, Muthiah MD, Syn N, Ng CH, Kim BK, Tamaki N, Ho CSH, Loomba R, Huang DQ
- KMID: 2534351
- Clin Mol Hepatol.
- 2022 Oct;28(4):864-875.
- doi: 10.3350/cmh.2022.0136
Background/Aims: Depression and anxiety are associated with poorer outcomes in patients with hepatocellular carcinoma (HCC). However, the prevalence of depression and anxiety in HCC are unclear. We aimed to establish... -
- CITED
-
- Close
- SHARE
-
- Close
